Genpharmasec Limited (BOM:531592)

Genpharmasec Revenue

Genpharmasec had revenue of 497.10M INR in the quarter ending June 30, 2026, with 312.77% growth. This brings the company's total for the last twelve months to 1.78B, up 337.77% year-over-year. In the fiscal year ending March 31, 2026, Genpharmasec had annual revenue of 1.40B with 314.98% growth. That makes Genpharmasec the 34,168th largest company in the world by revenue and 2,622nd in India.

• Revenue (ttm): 1.78B
• Revenue Growth: +337.77%
• P/S Ratio: 0.31
• Revenue / Employee: 136.62M
• Employees: 13
• Market Cap: 548.18M

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Pharmaceuticals 1.31B 93.5%
• Manufacturing & Processing 80.62M 5.8%
• Laboratory Testing 10.05M 0.7%

Fiscal year ended Mar 31, 2026 See the full Genpharmasec breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	1.40B	1.06B	314.98%
Mar 31, 2025	337.22M	33.16M	10.91%
Mar 31, 2024	304.06M	48.90M	19.16%
Mar 31, 2023	255.16M	-18.05M	-6.61%
Mar 31, 2022	273.21M	60.13M	28.22%

Data Source: S&P Global Market Intelligence Last updated: Aug 11, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 22, 2026

Data Sources Report a data error